DNLI Denali Therapeutics Inc. logo

DNLI Denali Therapeutics Inc.

Healthcare
$18.64-3.42%ClosedMarket Cap: $2.96B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

253

13F Shares

151,143,703

Ownership %

87.7%

New Positions

50

Increased Positions

137

Closed Positions

39

Reduced Positions

70

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
MNTLTema Neuroscience And Mental Health ETF15,1741.98%
SBIOALPS Medical Breakthroughs ETF129,1051.92%
GURUGlobal X - Guru Index ETF42,2581.57%
BBCVirtus Biotech Clinical Trials ETF15,1660.83%
XBI2,830,8540.74%
LABUDirexion Daily S&P Biotech Bull 3X ETF141,7780.56%
AGNGGlobal X - Aging Population ETF17,1330.41%
IBBiShares Biotechnology ETF1,055,2100.25%
VTWV91,8900.18%
IWNiShares Russell 2000 Value ETF1,149,6030.17%
NAJ1,149,6030.17%
TMSLT. Rowe Price Small-Mid Cap ETF127,2620.16%
AVSCAvantis U.S. Small Cap Equity ETF198,4630.16%
AVSCX11,2530.16%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF56,1700.16%
PRFZInvesco RAFI US 1500 Small-Mid ETF215,6030.15%
SMLFiShares U.S. Small-Cap Equity Factor ETF228,0400.13%
VWUAX3,037,8570.10%
VWUSX3,037,8570.10%
NJM3,471,3780.09%